We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$16.2B
AUM Growth
-$1.27B
(-7.2%)
Cap. Flow
-$1.42B
Cap. Flow
% of AUM
-8.75%
Top 10 Holdings %
Top 10 Hldgs %
18.5%
Holding
1,414
New
206
Increased
348
Reduced
372
Closed
450
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$456M |
| 2 |
Intel
INTC
|
+$290M |
| 3 |
Union Pacific
UNP
|
+$159M |
| 4 |
AT&T
T
|
+$143M |
| 5 |
Philip Morris
PM
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$394M |
| 2 |
AstraZeneca
AZN
|
+$307M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
TSMC
TSM
|
+$187M |
| 5 |
Canadian National Railway
CNI
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.82% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 9.75% |
| 4 | Industrials | 8.83% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Upbound Group
UPBD
$1.16B
| $1.67M | 0.01% |
60,668
+10,095
| +20% | +$308K |
|
|
DD
627
DELISTED
Du Pont De Nemours E I
DD
| $1.64M | 0.01% |
+24,219
| New | +$1.73M |
|
628
Middleby
MIDD
$6.08B
| $1.64M | 0.01% |
+16,000
| New | +$1.63M |
|
|
GSIG
629
DELISTED
GSI GROUP INC COM STK (CDA)
GSIG
| $1.64M | 0.01% |
123,028
-26,785
| -18% | -$359K |
|
630
Aon
AON
$76B
| $1.63M | 0.01% |
+17,000
| New | +$1.64M |
|
631
Unifirst Corp
UNF
$5.25B
| $1.63M | 0.01% |
13,867
-28,269
| -67% | -$3.34M |
|
632
Fossil Group
FOSL
$318M
| $1.63M | 0.01% |
+19,741
| New | +$1.82M |
|
|
FRGI
633
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $1.63M | 0.01% |
26,640
+18,700
| +236% | +$1.17M |
|
|
SHOR
634
DELISTED
ShoreTel, Inc.
SHOR
| $1.62M | 0.01% |
236,901
-231,252
| -49% | -$1.65M |
|
635
FormFactor
FORM
$9.17B
| $1.6M | 0.01% |
180,005
+61,337
| +52% | +$533K |
|
|
INFI
636
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $1.58M | 0.01% |
113,364
+100,817
| +804% | +$1.54M |
|
637
Choice Hotels
CHH
$4.8B
| $1.57M | 0.01% |
24,463
-12,571
| -34% | -$765K |
|
|
MCRL
638
DELISTED
MICREL INC
MCRL
| $1.55M | 0.01% |
102,982
+23,576
| +30% | +$344K |
|
|
ANN
639
DELISTED
ANN INC
ANN
| $1.55M | 0.01% |
+37,813
| New | +$1.38M |
|
640
Matsons
MATX
$6.18B
| $1.54M | 0.01% |
36,609
+20,846
| +132% | +$792K |
|
641
Sunstone Hotel Investors
SHO
$2.06B
| $1.54M | 0.01% |
92,442
-150,221
| -62% | -$2.58M |
|
|
WSTC
642
DELISTED
West Corporation
WSTC
| $1.53M | 0.01% |
45,390
-4,814
| -10% | -$160K |
|
643
Resources Connection
RGP
$145M
| $1.52M | 0.01% |
86,965
+14,308
| +20% | +$247K |
|
644
Integer Holdings
ITGR
$4.26B
| $1.49M | 0.01% |
28,339
-43,704
| -61% | -$2.07M |
|
645
Cato Corp
CATO
$66.1M
| $1.49M | 0.01% |
+37,570
| New | +$1.6M |
|
646
Lear
LEA
$8.18B
| $1.48M | 0.01% |
13,368
-28,286
| -68% | -$2.97M |
|
|
EXAC
647
DELISTED
Exactech Inc
EXAC
| $1.47M | 0.01% |
57,455
-2,600
| -4% | -$59.8K |
|
|
FDML
648
DELISTED
Federal-Mogul Holdings Corporation
FDML
| $1.46M | 0.01% |
110,008
+93,210
| +555% | +$1.29M |
|
|
ASCMA
649
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $1.46M | 0.01% |
36,700
+30,785
| +520% | +$1.37M |
|
650
AMC Entertainment Holdings
AMC
$2.31B
| $1.46M | 0.01% |
4,113
-3,358
| -45% | -$1.05M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2015 Portfolio in Review
As of Q1 2015, Arrowstreet Capital held 1,414 positions worth $16.2B, down 7.2% from $17.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $1.42B in Q1 2015, closing 450 positions and reducing 372 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $394M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Arrowstreet Capital opened a new position in Apple worth $470M.
- Arrowstreet Capital's largest Q1 2015 buy was Apple: 15,110,160 shares worth $470M.
- Arrowstreet Capital added most to Intel in Q1 2015, an estimated $290M increase.
- Arrowstreet Capital's biggest Q1 2015 reduction was AstraZeneca, cutting an estimated $307M.
- Arrowstreet Capital fully exited Teva Pharmaceuticals in Q1 2015, selling an estimated $394M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $16.2B portfolio in Q1 2015.
- Arrowstreet Capital opened 206 new positions and closed 450 in Q1 2015.
- Arrowstreet Capital's portfolio value fell 7.2% quarter-over-quarter to $16.2B.
Based on Arrowstreet Capital's 13F filing for Q1 2015, filed 15 May 2015.